486 related articles for article (PubMed ID: 30553469)
1. Evaluation of commercial kits for purification of circulating free DNA.
Diefenbach RJ; Lee JH; Kefford RF; Rizos H
Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 4 commercial kits for the extraction of circulating DNA from plasma.
Warton K; Graham LJ; Yuwono N; Samimi G
Cancer Genet; 2018 Dec; 228-229():143-150. PubMed ID: 29567030
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.
Lee EY; Lee EJ; Yoon H; Lee DH; Kim KH
Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32325682
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.
Jain M; Balatsky AV; Revina DB; Samokhodskaya LM
Mol Cell Probes; 2019 Feb; 43():13-19. PubMed ID: 30584912
[TBL] [Abstract][Full Text] [Related]
7. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
8. Cell-Free Microbial DNA Analysis: Effects of Blood Plasma and Serum Quantity, Biobanking Protocols, and Isolation Kits.
Nikitina D; Lukosevicius R; Tilinde D; Muskieta T; Hov JR; Melum E; Klovins J; Org E; Kiudelis G; Kupcinskas J; Skieceviciene J
Biopreserv Biobank; 2024 Feb; ():. PubMed ID: 38416864
[TBL] [Abstract][Full Text] [Related]
9. Performance comparison of commercial kits for isolating and detecting circulating tumor DNA.
Wang M; Huang X; Li X; Guo Q; Xu W; Zhao M; Wang X; Wang L; Lou J
Scand J Clin Lab Invest; 2021 Jul; 81(4):276-281. PubMed ID: 33999736
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients.
Shen N; Zhu B; Zhang W; Nian B; Xu X; Yu L; Ruan X; Chen S; Liu Y; Cao X; Shi X; Li Z; Huang X; Wang X; Chen C; Xiong L; Zhang D; Fu X; Zhang Y
Front Oncol; 2022; 12():891917. PubMed ID: 35600407
[TBL] [Abstract][Full Text] [Related]
11. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.
Terp SK; Pedersen IS; Stoico MP
J Mol Diagn; 2024 Apr; 26(4):310-319. PubMed ID: 38336350
[TBL] [Abstract][Full Text] [Related]
12. Simple and cost-effective laboratory methods to evaluate and validate cell-free DNA isolation.
Mojtabanezhad Shariatpanahi A; Rokni P; Shahabi E; Varshoee Tabrizi F; Kerachian MA
BMC Res Notes; 2018 Oct; 11(1):757. PubMed ID: 30352614
[TBL] [Abstract][Full Text] [Related]
13. A modified extraction method of circulating free DNA for epidermal growth factor receptor mutation analysis.
Yuan H; Zhu ZZ; Lu Y; Liu F; Zhang W; Huang G; Zhu G; Jiang B
Yonsei Med J; 2012 Jan; 53(1):132-7. PubMed ID: 22187243
[TBL] [Abstract][Full Text] [Related]
14. Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis.
Huebner H; Lubrich H; Blum S; Antoniadis S; Lermann J; Ekici A; Fasching PA; Beckmann MW; Ruebner M; Burghaus S
Reprod Biomed Online; 2021 Nov; 43(5):788-798. PubMed ID: 34493460
[TBL] [Abstract][Full Text] [Related]
15. Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma.
Mazurek AM; Fiszer-Kierzkowska A; Rutkowski T; Składowski K; Pierzyna M; Scieglińska D; Woźniak G; Głowacki G; Kawczyński R; Małusecka E
Cancer Biomark; 2013; 13(5):385-94. PubMed ID: 24440979
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma.
Mauger F; Dulary C; Daviaud C; Deleuze JF; Tost J
Anal Bioanal Chem; 2015 Sep; 407(22):6873-8. PubMed ID: 26123439
[TBL] [Abstract][Full Text] [Related]
17. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
Nesic M; Bødker JS; Terp SK; Dybkær K
Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
[TBL] [Abstract][Full Text] [Related]
18. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.
Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G
Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419
[TBL] [Abstract][Full Text] [Related]
20. Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma.
de Kock R; Deiman B; Kraaijvanger R; Scharnhorst V
J Mol Diagn; 2019 Sep; 21(5):895-902. PubMed ID: 31229652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
